Most immunosuppressive meds not tied to worse COVID-19 outcomes
Dec 01, 2021
Except for rituximab, no increased risk was seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy.
Decline in infectious conjunctivitis during COVID-19 pandemic
Nov 29, 2021
There was a decrease in emergency department encounters for nonallergic conjunctivitis after the adoption of public health measures to curb COVID-19.
30 percent of hospital-based healthcare personnel unvaccinated
Nov 22, 2021
Vaccination coverage was highest among HCP in children’s hospitals, followed by those in short-term acute care hospitals, long-term acute care hospitals, and critical access hospitals (77, 70.1,...
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
Florida lawmakers take on federal COVID-19 vaccination mandates
By
Kimberly Bonvissuto
Nov 19, 2021
A series of state bills aimed at dismantling employer COVID-19 vaccine mandates is headed to Florida Gov. Ron DeSantis’ desk, potentially making the state the first to fine employers for requiring vaccinations.
Fewer deaths reported with enrollment in COVID-19 remote monitoring
Nov 18, 2021
The remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to the emergency department sooner.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.
Slimmer, $1.75T Build Back Better framework calls for ‘historic’ investment in older adults, but...
By
Kimberly Bonvissuto
Oct 29, 2021
A pared down, $1.75 trillion social spending package framework announced Thursday by President Biden is being called a “historic step” for older adults, but greater investments still are necessary...
REGEN-COV reduces risk for COVID-19 hospitalization, death
Oct 01, 2021
Among outpatients with COVID-19 at high risk, the risk for hospitalization and death was reduced with the monoclonal antibody combo versus placebo.
No change found in pattern of adverse events after third COVID-19 shot
Sep 30, 2021
Of the 12,591 individuals who completed a health check-in for all three doses, 79.4 and 74.1% reported local or systemic reactions, respectively.